Clinical Trial Update: Rasagiline and Apathy in Parkinson's Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated rasagiline for apathy in Parkinson's disease and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• RASAGILINE (rasagiline)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Parkinson's Disease | Phase 4 | Status: COMPLETED